Current Screening Guidelines: Can Tomosynthesis Shift the Equation? (Rafferty)

Current Screening Guidelines:  Can Tomosythesis Shift the Equation? 

Elizabeth A. Rafferty, MD
Director of Breast Imaging Programs
L&M Radiology
Medical Director
Women's Health Imaging
Andover, Massachusetts

Target audience:  Physicians who interpret breast screening images

Learning Objectives | At the conclusion of this presentation, the participant will be able to:

1. Describe current Breast Tomosynthesis screening guidelines and recommendations
2. Describe the key statistical and literature reviews conducted by critical bodies
3. Describe the impact of diagnosis across each age range using recent studies and source data
4. Describe the impact of tomosynthesis in increasing cancer detection along with a reduction in false positives

Release Date: November 30, 2017
Expiration Date: November 29, 2020

Credit: 1 AMA PRA Category 1 Credit™


Elizabeth A. Rafferty, MD 
Investigator-development of tomosynthesis, Consultant: Hologic, Inc. – received research grant


Heidi M. Wilson


World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

World Class CME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit may be used towards ABR MOC Part 2 SA-CME requirement.

The American Society of Radiologic Technologists has approved this activity for Category A CE credits as follows. The American Registry of Diagnostic Medical Sonographers (ARDMS) accepts all American Society of Radiologic Technologists (ASRT) Category A credits as fulfilling their requirements for continuing education (CE) credits.

Activity Title                                                                                        Category A CE Credits
Current Screening Guidelines:  Can Tomosynthesis Shift the Equeation?          1.0 CE

World Class CME relies on its CME faculty to provide program content that is evidence-based and free of commercial bias. Therefore, in accordance with ACCME standards, any faculty, program director, reviewer and/or provider industry relationships will be disclosed and resolved. Speakers are required to openly disclose any limitations of data or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

This activity is supported by an unrestricted educational grant from Hologic, Inc.

Instructions to Receive Credit:  After viewing the video, click on the “Take the Quiz” button and complete the post-activity quiz.  After completing the quiz, fill out the evaluation form and submit.  Your CME certificate will then be emailed to you.


Cady B, et al (ASCO) 2009 Breast Cancer Symposium

Oeffinger KC, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA October 20 2015;314(15):1599-1614

Friedewald, SM, Rafferty EA, Rose SL, et al. Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography. JAMA 2014;311(24):2499-2507

Rafferty, EA, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA 2016;315(16):1784-1786

Rafferty EA et al. Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography. Breast Cancer Research and Treatment August 2017, Volume 164, Issue 3, pp 659-666

Take The Quiz

“World Class CME has truly helped me stay on top of my continuing ed. The staff, the process, and the course substance is all top notch.”